(Q36283516)

13 August 2017

1 reference

title

Pharmacological modulation of plaque instability (English)

1 reference

13 August 2017

A Mezzetti

1

1 reference

13 August 2017

publication date

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

14

1 reference

13 August 2017

issue

9

1 reference

13 August 2017

page(s)

769-772

1 reference

Coronary Plaque Disruption

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Current concepts of the pathogenesis of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Fatty acids and their prostaglandin derivatives: inhibitors of proliferation in aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2218OA

10.1191/0961203305LU2218OA

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference